Schedule 5 WAIVER, REDUCTION OR REFUND OF CAPITAL FEES

Changes not yet applied. Later legislation changes this provision in ways not yet written into the text below:

• Sch. 5 para. 1A(1A) inserted by Medicines for Human Use and Medical Devices (Fees Amendments) 2004 reg. 14
• Sch 5, para 1A added by Medicines for Human Use (Fees and Miscellaneous Amendments) 2003 reg 13(1), (2)
• Sch 5, para 2 am by Medicines for Human Use (Fees and Miscellaneous Amendments) 2003 reg 13(1), (3)
• Sch 5, para 2C added by Medicines for Human Use (Fees Amendments) 2005 reg 5
• Sch.5, para.3(1)(c) amended by Medicines (Products for Human Use—Fees) 1996 reg.7(1)
• Sch.5, para.4A added by Medicines (Products for Human Use—Fees) 1996 reg.7(2)
• Sch.5, para,6(3) revoked by Medicines (Products for Human Use—Fees) 1996 reg.7(3)
• Sch.5, para.7 added by Medicines (Products for Human Use—Fees) 1996 reg.7(4)
• Sch 5, para 2A added by Medicines for Human Use and Medical Devices (Fees and Miscellaneous Amendments) 2001 reg 5(12)
• Sch 5, para 6 am by Medicines for Human Use and Medical Devices (Fees and Miscellaneous Amendments) 2001 reg 5(13)
• Sch 5, para 2 am by Medicines for Human Use and Medical Devices(Fees Amendments) 2003 reg 4(1), (8)(a)
• Sch 5, para 5A added by Medicines for Human Use and Medical Devices(Fees Amendments) 2003 reg 4(1), (8)(b)
• Sch. 5 para. 3(1) words substituted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(2)(a)(i)
• Sch. 5 para. 3(1) words substituted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(2)(a)(ii)
• Sch. 5 para. 3(1) words substituted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(2)(a)(iii)
• Sch. 5 para. 3(1)(a) words inserted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(2)(a)(iv)
• Sch. 5 para. 3(3) words substituted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(2)(b)(i)
• Sch. 5 para. 3(3) words substituted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(2)(b)(ii)
• Sch. 5 para. 3(3) words inserted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(2)(b)(iii)
• Sch. 5 para. 4 words inserted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(3)
• Sch. 5 para. 4A words substituted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(4)
• Sch. 5 para. 5(1) Sch. 5 para. 5(5) renumbered as Sch 5. para. 5(1) by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(5)
• Sch. 5 para. 5(1) words inserted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(5)(a)(i)
• Sch. 5 para. 5(1) words inserted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(5)(a)(ii)
• Sch. 5 para. 5(2) inserted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(5)(b)
• Sch. 5 para. 8 inserted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(6)
• Sch 5, para 2B rev in pt by Medicines for Human Use (Fees Amendments) 2005 reg 19(1), (2)
• Sch 5, para 2D added by Medicines for Human Use (Fees Amendments) 2005 reg 19(1), (3)
• Sch 5, para 3 am by Medicines for Human Use (Fees Amendments) 2005 reg 19(1), (4)(a), (b)(i)
• Sch 5, para 3 rev in pt by Medicines for Human Use (Fees Amendments) 2005 reg 19(1), (4)(b)(ii)
• Sch 5, para 4A am by Medicines for Human Use (Fees Amendments) 2005 reg 19(1), (5)
• Sch. 5 para. 6 words substituted by Medicines (Codification Amendments Etc.) 2002 reg. 16(l)
• Sch 5, para 2B added by Medicines for Human Use and Medical Devices (Fees and Miscellaneous Amendments) 2002 reg 5(1), (8)